12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Stemline completes IPO

Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y.
Business: Cancer
Date completed: 1/28/13
Type: IPO

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >